Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.21.1
Segment Disclosures
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segment Disclosures Segment Disclosures
 
The Company has two reportable segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.

The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
  EksoHealth EksoWorks Total
Three months ended March 31, 2021      
Revenue $ 1,727  $ 183  $ 1,910 
Cost of revenue 542  133  675 
Gross profit $ 1,185  $ 50  $ 1,235 
Three months ended March 31, 2020      
Revenue $ 1,191  $ 277  $ 1,468 
Cost of revenue 618  213  831 
Gross profit $ 573  $ 64  $ 637 

Geographic information for revenue based on location of customers is as follows:
  Three Months Ended March 31,
  2021 2020
United States $ 1,041  $ 1,249 
All Other 869  219 
  $ 1,910  $ 1,468